Lumbar Spondylolisthesis: when insurers say no, reviewers often say yes
In 13 published external-review decisions involving lumbar spondylolisthesis, independent physician reviewers overturned the insurer’s denial 7.7% of the time.
What the insurer actually argued
| Reason given | Decisions | Overturned |
|---|---|---|
Medical Necessity The plan said the care wasn’t medically necessary. The most common fight, and the most winnable. | 10 | 10% |
Experimental/Investigational The plan called the treatment unproven. These turn on published evidence, so the appeal is a literature argument. | 3 | 0% |
Where the denial was overturned
Nature of Statutory Criteria/ Case Summary: The enrollee requested the medication, OxyContin. She has a history of lumbar spondylolisthesis that causes back and radiating leg pain rated as ten out of ten. Findings: The physician reviewer found that Her pain worsens with prolonged bending, standing, walking, coughing, and sneezing. She has taken narcotics and muscle relaxers, had physical therapy, chiropractic care, a spinal cord stimulator implantation, and steroids (both oral and epidural injections) for chronic pain. Spinal fusion surgery at the levels of L4-L5 and L5-S1 was performed. Post-operatively, a patient controlled anesthesia (PCA) pump with Dilaudid for pain management and physical therapy were provided. The enrollee had excessive pain and could only stand at the side of the bed for physical therapy, so she remained on the PCA pump.
Where the denial was upheld
Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for (1) L5-S1 anterior lumbar interbody fusion surgery and (2) L4-L5 fusion surgery. Medical literature state, “A trial of conservative therapy may be considered for patients with low-grade spondylolisthesis presenting with radiculopathy and/or pseudoclaudication. These options may include physical therapy, epidural steroid injection, and pain medications. If unresolved, surgical options may include decompression alone or decompression and fusion.” Researchers state, “Patients with symptomatic lumbar spondylolisthesis may first be treated with conservative management strategies including, but not limited to, non-narcotic and narcotic pain medications, epidural steroid injections, transforaminal injections, and physical therapy.
Nature of Statutory Criteria/Case Summary: The patient requested authorization and coverage for exploration of spinal fusion; lumbar spine fusion; spine fusion extra segment; insertion of interbody biomechanical device; insertion of spine fixation device; autograft spine surgery local from same incision; bone allograft morsel; and bone marrow aspiration for bone grafting of the requested lumbar spine surgery for removal of lumbar hardware, exploration of fusion mass, possible re-instrumentation, possible re-fusion, and possible revision decompression. Patients should be cautioned that hardware removal after posterior spinal fusion may not provide complete pain relief. Furthermore, there is risk for curve progression following removal of instrumentation, particularly in the setting of infection.
Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California outcomes — every state runs an equivalent external review, but the rates here are California’s. Excerpts are quoted verbatim from the public record and describe this condition generally, not any individual case.
These outcomes come from California’s external review program — an independent physician panel whose decision binds the insurer. Every state has an equivalent, and internal appeals succeed even more often. If your care for lumbar spondylolisthesis was denied, the published record says the denial is worth fighting.
SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY